Audit of the Drug Enforcement Administration's Prescription Drug Take Back Activities
- NARA ID
- audit-drug-enforcement-administrations-prescription-drug-take-back-activities
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Audit
- Released
- 2020-09-29
- Slug
- doj-oig-audit-drug-enforcement-administrations-prescription-drug-take-back-activities
- Indexed
- 2026-04-27 05:03:38
More from DOJ OIG — Drug Enforcement Administration
- Audit of the Drug Enforcement Administration’s Use of Polygraphs in the Pre-employment and Foreign Vetting Processes
- Review of the Drug Enforcement Administration’s Accounting of Drug Control Funding Fiscal Year 2025
- Audit of the Drug Enforcement Administration's Personnel Resource Management and Casework
- Memorandum for the Deputy Attorney General: Recommendation for the Drug Enforcement Administration to Review whether its Field Offices are Engaging in Unlawful Fundraising on Behalf of the Drug Enforcement Administration Survivors Benefit Fund
- Investigative Summary: Findings of Misconduct by a Drug Enforcement Administration (DEA) Executive Assistant for Misuse of Position, Prohibited Association with a Former DEA Confidential Source, and Soliciting and Accepting Gifts from the Former DEA Confidential Source
- Audit of the Drug Enforcement Administration’s Community-Based Efforts to Combat the Opioid Crisis
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.